Dr Abdelghani actively contributes to various committees within the Clinical TMS Society, notably the Education Committee. He imparts his expertise through lectures and hands-on training sessions on TMS and neuromodulation, both nationally and internationally. Additionally, he is a valued faculty member of the PULSES TMS training course, a program offered by the Clinical TMS Society across different countries.
Dr Abdelghani is a board member and one of the founding members of the Foundation for Advancement of Clinical TMS (FACTMS). Presently, he serves as the Chair of the Clinics Expansion Committee within the foundation. This committee is dedicated to the establishment of evidence-based TMS clinics in underserved communities across the globe, reflecting the commitment to extending the benefits of TMS therapy to those in need.
He has undergone formal TMS training at two of the world’s leading TMS centres: Harvard University in the USA and the Medical University of South Carolina (MUSC), under the guidance of Prof Mark George. Notably, Prof George was a pioneer in using TMS to treat depression in the early 1990s.
He has also actively participated in TMS clinical research, aiming to enhance the efficiency and accessibility of TMS treatment across diverse patient groups. Notably, he was the London Principal Investigator for the BRIGhTMIND TMS Randomised Control Trial (RCT). This is the largest TMS clinical RCT in the UK.
Dr. Abdelghani’s NHS journey as a Consultant Psychiatrist commenced in 2013, with his role at the Camden & Islington NHS Foundation Trust dating back to 2014. Alongside his TMS endeavours, he has excelled as a recognized Adult ADHD expert. Having led the Adult ADHD Service at Camden and Islington NHS Foundation Trust for nearly 8 years, he transitioned from this role in February 2022 to focus on expanding his private practice.
Since joining Camden & Islington NHS Foundation Trust, he has served as a consultant psychiatrist within the Complex Depression, Anxiety, and Trauma (CDAT) unit. Notably, he spearheads the Trust’s TMS service, which he established in 2016. Dr. Abdelghani’s contributions have garnered him two clinical excellence awards from the Trust, recognizing his dedication to enhancing NHS services and delivering high-quality care.
Dr Abdelghani completed his post-graduate psychiatric training at South London & Maudsley NHS Foundation Trust
(SLaM), an eminent mental health organization renowned globally for its excellence. Collaborating with distinguished professors and clinicians during his training at the National Affective Disorders Service, he ventured into pioneering research involving Deep Brain Stimulation (DBS) for treatment-resistant depression. As the primary psychiatrist at
King’s College London site, he played a pivotal role in this multicentre international study.
In 2009, he became a member of the Royal College of Psychiatrists. In 2020, he earned the distinguished title of Fellow of the college, a recognition of his notable contributions to the field of psychiatry. In 2012, Dr. Abdelghani achieved an MSc in Clinical Neuroscience from King’s College London. Following the completion of his higher psychiatry training at SLaM, he worked as a consultant psychiatrist at the same institution for nearly a year. Subsequently, he embraced his current role at the Camden & Islington NHS Foundation Trust, driven by the aim of establishing specialized services for depression and adult ADHD.
In 2015, Dr Abdelghani established Nurify Medical formerly known as Dyad Medical, private practice situated in Harley Street. Over the years, he has emerged as one of the most prominent and well-respected private psychiatrists in London.
